[HTML][HTML] A multicenter, randomized, double-blind, duloxetine-controlled, non-inferiority trial of desvenlafaxine succinate extended-release in patients with major …

Q Zhao, B Fu, N Lyu, X Xu, G Huang, Y Tan… - Journal of Affective …, 2023 - Elsevier
Background Desvenlafaxine and duloxetine are selective serotonin and norepinephrine
reuptake inhibitors. Their efficacy has not been directly compared using statistical …

A multicenter, randomized, double-blind, duloxetine-controlled, non-inferiority trial of desvenlafaxine succinate extended-release in patients with major depressive …

Q Zhao, B Fu, N Lyu, X Xu, G Huang, Y Tan… - Journal of Affective …, 2023 - europepmc.org
Background Desvenlafaxine and duloxetine are selective serotonin and norepinephrine
reuptake inhibitors. Their efficacy has not been directly compared using statistical …

A multicenter, randomized, double-blind, duloxetine-controlled, non-inferiority trial of desvenlafaxine succinate extended-release in patients with major depressive …

Q Zhao, B Fu, N Lyu, X Xu, G Huang, Y Tan, X Xu… - 2023 - pubmed.ncbi.nlm.nih.gov
Background Desvenlafaxine and duloxetine are selective serotonin and norepinephrine
reuptake inhibitors. Their efficacy has not been directly compared using statistical …